J Pathol Transl Med.  2016 Mar;50(2):113-121. 10.4132/jptm.2015.10.30.

Meningeal Solitary Fibrous Tumors with Delayed Extracranial Metastasis

• Han N
• Kim H
• Min SK
• Paek SH
• Park CK
• Choi SH
• Chae UR
• Park SH

• KMID: 2211378
• DOI: http://doi.org/10.4132/jptm.2015.10.30

Abstract

BACKGROUND
The term solitary fibrous tumor (SFT) is preferred over meningeal hemangiopericytoma (HPC), because NAB2-STAT6 gene fusion has been observed in both intracranial and extracranial HPCs. HPCs are now considered cellular variants of SFTs.
METHODS
This study analyzes 19 patients with STAT6-confirmed SFTs, who were followed for over 11 years in a single institution. Ten patients (10/19, 56.2%) had extracranial metastases (metastatic group), while the remainder (9/19) did not (non-metastatic group). These two groups were compared clinicopathologically.
RESULTS
In the metastatic group, the primary metastatic sites were the lungs (n = 6), bone (n = 4), and liver (n = 3). There was a mean lag time of 14.2 years between the diagnosis of the initial meningeal tumor to that of systemic metastasis. The median age at initial tumor onset was 37.1 years in the metastatic group and 52.5 in the non-metastatic group. The 10-year survival rates of the metastatic- and non-metastatic groups were 100% and 33%, respectively. The significant prognostic factors for poor outcomes on univariate analysis included advanced age (≥45 years) and large initial tumor size (≥5 cm). In contrast, the patients with higher tumor grade, high mitotic rate (≥5/10 high-power fields), high Ki-67 index (≥5%), and the presence of necrosis or CD34 positivity showed tendency of poor prognosis but these parameters were not statistically significant poor prognostic markers.
CONCLUSIONS
Among patients with SFTs, younger patients (<45 years) experienced longer survival times and paradoxically had more frequent extracranial metastases after long latent periods than did older patients. Therefore, young patients with SFTs require careful surveillance and follow-up for early detection of systemic metastases.

Keyword

Central nervous system; Hemangiopericytoma; Neoplasm metastases; NAB2-STAT6 gene fusion; Solitary fibrous tumors

MeSH Terms

Central Nervous System
Diagnosis
Follow-Up Studies
Gene Fusion
Hemangiopericytoma
Humans
Liver
Lung
Meningeal Neoplasms
Necrosis
Neoplasm Metastasis*
Prognosis
Solitary Fibrous Tumors*
Survival Rate

Figure

• 

  Fig. 1. Representative brain magnetic resonance images and histopathology of the primary brain tumor from case 10. (A) Prior to radiation therapy. A large, solid and cystic mass is observed in the right frontoparietal lobe with strong enhancement. There was severe mass effect. Intratumoral vessels were identified. (B) After preoperative radiation therapy. The tumor decreased in the size after radiation therapy. (C) The tumor demonstrates low cellular and edematous areas with staghorn-shaped vasculature. The tumor cells may have been ablated by radiotherapy. (D) Aberrant STAT6 nuclear positivity is observed in the primary brain tumor.

• 

  Fig. 2. Computed tomography (CT) and pathology of a metastatic solitary fibrous tumor from case 10. (A) Liver CT scan showing a large, 12-cm soft tissue mass in the right lobe with prominent feeding vessels. (B) The cut surface of a hepatic tumor specimen showing a well-circumscribed, yellowish-tan-colored, solid tumor with multifocal necrosis, and hemorrhage with dilated vessels. (C) Microscopic examination of the liver mass reveals small, discohesive tumor cells with oval nuclei and fine chromatin. Staghorn-shaped hyalinized vessels and osteoclast-like multinucleated giant cells are identified. (D) Tumor cells are focally positive for CD34 on immunohistochemical staining. (E) Aberrant STAT6 nuclear positivity is observed in the metastatic tumor cells in the liver. (F) Ultrastructurally, the tumor is composed of sheets of oval to elongate cells around small capillaries. The tumor cells have nuclei with an oval or indented appearance, and fine, granular chromatin. Skein-like nuclei are also present. The individual tumor cells are surrounded by a thick, electron-dense, amorphous, external laminar material (arrowheads; uranyl acetate and lead citrate, × 5,000).

• 

  Fig. 3. Kaplan-Meier survival curves of patients with solitary fibrous tumors according to the presence or absence of systemic metastases. (A) Paradoxically, the patients with systemic metastases had better prognosis than did those without metastasis. Metastases usually arose approximately 10 years after the initial tumor development. Therefore, only longer survivors developed systemic metastases. (B) Younger patients lived longer and had better survival. The age cut-off to demonstrate a meaningful survival difference is 45 years. (C) Patients with an initial tumor size > 5 cm have poorer survival than did those with smaller tumors. (D) The age of tumor onset is significantly younger in patients with systemic metastases than it is in patients without metastases. The median ages of onset in patients with and without systemic metastases are 37.1 years and 52.5 years, respectively.

Reference

1. Klemperer P, Coleman BR. Primary neoplasms of the pleura: a report of five cases. Am J Ind Med. 1992; 22:1–31.

2. Fletcher CD, Bridege JA, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. Lyon: IARC Press;2013.

3. Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system: a clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 2003; 127:432–9.

4. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013; 45:131–2.

5. Yu HC, Cho BH, Kim YK, Noh SJ, Moon WS. Solitary fibrous tumor of the liver: a case report. Korean J Pathol. 2010; 44:536–9.

6. Park BJ, Kim YI, Hong YK, Jeun SS, Lee KS, Lee YS. Clinical analysis of intracranial hemangiopericytoma. J Korean Neurosurg Soc. 2013; 54:309–16.

7. Pistolesi S, Fontanini G, Barellini L, et al. Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report. Tumori. 2004; 90:147–50.

8. Kim NR, Ro JY, Shin KH, Paik HJ, An JS, Ha SY. Solitary fibrous tumor of the conjunctiva with heretofore undescribed pathologic findings. Korean J Pathol. 2011; 45:315–8.

9. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006; 48:63–74.

10. Metellus P, Bouvier C, Guyotat J, et al. Solitary fibrous tumors of the central nervous system: clinicopathological and therapeutic considerations of 18 cases. Neurosurgery. 2007; 60:715–22.

11. Ambrosini-Spaltro A, Eusebi V. Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. Virchows Arch. 2010; 456:343–54.

12. Fuller C. WHO classification of tumours of the central nervous system, fourth edition. J Neuropathol Exp Neurol. 2008; 67:260.

13. Ogawa K, Tada T, Takahashi S, et al. Malignant solitary fibrous tumor of the meninges. Virchows Arch. 2004; 444:459–64.

14. Ng HK, Choi PC, Wong CW, To KF, Poon WS. Metastatic solitary fibrous tumor of the meninges: case report. J Neurosurg. 2000; 93:490–3.

15. Someya M, Sakata KI, Oouchi A, Nagakura H, Satoh M, Hareyama M. Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. Jpn J Clin Oncol. 2001; 31:548–52.

16. Dufour H, Métellus P, Fuentes S, et al. Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery. 2001; 48:756–62.

17. Chang CC, Chang YY, Lui CC, Huang CC, Liu JS. Meningeal hemangiopericytoma with delayed multiple distant metastases. J Chin Med Assoc. 2004; 67:527–32.

18. Hayashi Y, Uchiyama N, Nakada M, et al. A reevaluation of the primary diagnosis of hemangiopericytoma and the clinical importance of differential diagnosis from solitary fibrous tumor of the central nervous system. Clin Neurol Neurosurg. 2009; 111:34–8.

19. Hoshi M, Araki N, Naka N, et al. Bone metastasis of intracranial meningeal hemangiopericytoma. Int J Clin Oncol. 2005; 10:208–13.

20. Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013; 45:180–5.

21. Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013; 125:651–8.

22. Fisher C. Immunohistochemistry in diagnosis of soft tissue tumours. Histopathology. 2011; 58:1001–12.

23. Tavassoéli FA, Devilee P. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press;2003.

24. Sakai Y, Kupelioglu AA, Yanagisawa A, et al. Origin of giant cells in osteoclast-like giant cell tumors of the pancreas. Hum Pathol. 2000; 31:1223–9.

25. Ushiku T, Shinozaki A, Uozaki H, et al. Gastric carcinoma with osteoclast-like giant cells: lymphoepithelioma-like carcinoma with Epstein-Barr virus infection is the predominant type. Pathol Int. 2010; 60:551–8.

26. Insabato L, Di Vizio D, Ciancia G, Pettinato G, Tornillo L, Terracciano L. Malignant gastrointestinal leiomyosarcoma and gastrointestinal stromal tumor with prominent osteoclast-like giant cells. Arch Pathol Lab Med. 2004; 128:440–3.

27. Friedrichs N, Testi MA, Moiraghi L, et al. Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entity. Int J Surg Pathol. 2005; 13:313–8.

28. Wooff J, Werner D, Murphy J, Walsh N. Osteoclast-like giant cell reaction associated with cutaneous squamous cell carcinoma: a report of 2 cases and review of the literature. Am J Dermatopathol. 2009; 31:282–7.

29. Al-Brahim N, Salama S. Malignant melanoma with osteoclast-like giant cells: an unusual host response: immunohistochemical and ultrastructural study of three cases and literature review. Am J Dermatopathol. 2005; 27:126–9.

30. Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011; 117:4939–47.

31. Chamberlain MC, Glantz MJ. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery. 2008; 63:720–6.